The Legends of Saint Barbara.London: Royal Artillery Institution, 1955
2.
FischerE.Aus Meinen Leben.Berlin: Julius Springer, 1922
3.
FischerE., MeringJ.Ueber eine Klasse von Schlafmitteln.Ther Gegenw1903; 5: 97–101
4.
WinternitzH., ZuntzN.Josef v Mering.Muench Med Wschr1908; 8: 400–2
5.
Report of the Advancements of Pharmaceutical Chemistry and Therapeutics.Darmstadt: Merck, 1903
6.
Kaiserliches Patentamt. Patent No. 293163. Issued to Farbenfabriken worm. Friedr. Bayer & Co, 16 July 1916
7.
PrattW.D.The Abbott Almanac: 100 Years of Commitment to Quality Health Care.Elmsford, NY: Benjamin, 1987
8.
HennyK.M.Das intravenöse Narkotikum Evipan-Natrium (Hexo-barbital-Natrium) und seine Anwendung [Thesis].Rheinsch-Westfallischen Technischen Hochschule Aachen, 1997
9.
HalfordF.J.A critique of intravenous anesthesia in war surgery.Anesthesiology1943; 4: 67–9
10.
LundyJ.S.Intravenous anesthesia: preliminary report of the use of two new thiobarbiturates.Proc Mayo Clin1935; 10: 536–43
11.
TatumA.L.The present status of the barbiturate problem.Physiol Rev1939; 19: 472, 502
12.
SwannJ.R.Academic Scientists and the Pharmaceutical Industry.Baltimore: Johns Hopkins University Press, 1988
13.
BillupsN.F.American Drug Index.St Louis: Facts & Comparisons, 2002
14.
Archives, Eli Lilly and Company, Indianapolis, IN, General letter No. 120, 28 October 1920
15.
PorterR.The Greatest Benefit to Mankind. A Medical History of Humanity from Antiquity to the Present.London: Harper-Collins, 1997
16.
GoldsteinS.W.Barbiturates: a blessing and a menace.J Am Pharm Assoc1947; 6: 5–14
17.
Editorial.Narcotic control of barbiturates.J Am Pharm Assoc1946; 7: 240
18.
KahnE.J.JrAll in a Century—The First 100 Years of Eli Lilly and Company.West Cornwall, CN: Kahn, 1976
19.
DuttaS.N.Sedatives-hypnotics. In: PradhanS.E., ed. Drug Abuse—Clinical and Basic Aspects.St Louis: Mosby, 1977: 102–15
20.
DunlopD.The use and abuse of psychotropic drugs.Proc R Soc Med1970; 63: 1279–82
21.
WatsonW.A., LitovitzT.L., RodgersG.C.. 2002 annual report of the American Association of Poison Control Centers-Toxic Exposure Surveillance System.Am J Emerg Med2002; 21: 353–421
22.
BreuningS.E., PolingA.D.Drugs and Mental Retardation.Springfield: Charles C Thomas, 1982